Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Beigene Ltd Ads
(NQ:
BGNE
)
334.90
USD
+2.43 (+0.73%)
Official Closing Price
Updated: 7:06 PM EST, Feb 24, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
215,400
Open
326.68
Bid (Size)
300.05 (1)
Ask (Size)
334.55 (1)
Prev. Close
332.47
Today's Range
322.25 - 339.89
52wk Range
118.55 - 388.97
Shares Outstanding
53,760,296
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
February 17, 2021
Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists
From
Business Wire News Releases
BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia
February 17, 2021
BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia
From
Business Wire News Releases
Performance
YTD
+28.31%
+28.31%
1 Month
-11.15%
-11.15%
3 Month
+26.78%
+26.78%
6 Month
+34.36%
+34.36%
1 Year
+111.19%
+111.19%
More News
Read More
BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma
January 27, 2021
From
Business Wire News Releases
BeiGene's US Application For BRUKINSA In A Type Of Lymphoma, Accepted For Review
February 17, 2021
Tags
BGNE
News
General
From
Benzinga
Stocks Showing Improving Market Leadership: Beigene Earns 84 RS Rating
Today 3:00 EST
From
Investor's Business Daily
Week In Review: Yuanxin Raises $465 Million For Online Healthcare Company Miaoshou Doctor
February 20, 2021
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT® (Siltuximab for Injection) in China
January 25, 2021
From
Business Wire News Releases
bye bye BGNE and Mexichem
February 09, 2021
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Stock Squeeze Remnants
February 01, 2021
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Week In Review: Matridx Raises $32 Million For AI/CRISPR-Cas Pathogen Metagenomics Diagnostic Devices
January 30, 2021
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
Tags
PRTA
News
Pre/Market Outlook
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.